ClinicalTrials.gg
Drug

Triptorelin clinical trials

Also written Decapeptyl and Trelstar.

Includes 10 studies of Triptorelin acetate.

studies test it
102
open now
17
in phase 3
36
first study started
2002

How each study uses triptorelin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the triptorelin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Jun 2000 · TRELSTAR · NDA 020715 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Triptorelin
36
Pamorelin
8
Triptorelin Pamoate
7
Trelstar Depot
5
Gonapeptyl
5

Brand

Decapeptyl
20
Trelstar
5
Decapeptyl 0.1 mg
2
Decapeptyl 0.2 mg
1

Development codes

AY-25650
1
FP-014
1

Other names

Tryptorelin
1

Studies by the year they started

102 studies that test it; most in 2012 (9)

Studies that test triptorelin, by start year
YearStudies
20022
20035
20042
20053
20064
20074
20083
20091
20102
20115
20129
20135
20147
20152
20168
20178
20182
20193
20201
20215
20226
20235
20243
20255
20262

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
23
Phase 3
36
Phase 4
27
No phase
19

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 81

Ipsen (13) · ETOP IBCSG Partners Foundation (4) · Sheba Medical Center (3) · Debiopharm International SA (3) · UNICANCER (2) · Alexandria University (2) · Centre Hospitalier Universitaire Ibn Rochd (2) · V.K.V. American Hospital, Istanbul (2)

Often tested with

Tested in the same studies.

Leuprolide (8) · Degarelix (7) · Bicalutamide (6) · Goserelin (6) · Chorionic Gonadotropin (6) · Exemestane (4) · Flutamide (3) · Estradiol (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Triptorelin is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 4, 2 in phase 3

Studies that test triptorelin, phase 3 first.

Studies

Open first, then newest update. How each study uses triptorelin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 102

See all 102 studies that test triptorelin →

Given beside what is tested · 22 — triptorelin is usual care or a partner of the new treatment

Showing 20 of 22.

As the comparator · 15 — what is tested is compared with triptorelin

Codes

What other systems call triptorelin · ClinicalTrials.gg INT008588

  • MeSH (NLM) D017329Triptorelin PamoateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 9081Y98W2VTRIPTORELINOne source FDA
  • RxNorm 38782One source FDA
  • NCI Thesaurus C1267TriptorelinOne source FDA

Also registered as triptorelin pamoate (UNII 08AN7WA2G0 · RxNorm 338529).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.